EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹2.00 Cr | ₹4.52 Cr | ₹4.15 Cr | ₹3.89 Cr | ₹3.58 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of EVEREST ORGANICS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹2.00 Cr |
| Mar2024 | ₹4.52 Cr |
| Mar2023 | ₹4.15 Cr |
| Mar2022 | ₹3.89 Cr |
| Mar2021 | ₹3.58 Cr |
How is Deferred Tax Assets / Liabilities of EVEREST ORGANICS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.00 Cr | -55.63 | |
| Mar2024 | ₹4.52 Cr | 8.95 | |
| Mar2023 | ₹4.15 Cr | 6.61 | |
| Mar2022 | ₹3.89 Cr | 8.54 | |
| Mar2021 | ₹3.58 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹234.4 Cr | -3.2% | 5.3% | -37.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -3.2% |
5.3% |
-37.5% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses